Yifeng Mao
Overview
Explore the profile of Yifeng Mao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chandramouli S, Mao Y, Hoefer M
Phys Rev E
. 2024 Apr;
109(3-1):034212.
PMID: 38632737
The existence and properties of envelope solitary waves on a periodic traveling-wave background, called traveling breathers, are investigated numerically in representative nonlocal dispersive media. Using a fixed-point computational scheme, a...
2.
Tian Y, Mao Y, Tang Z, Hu M
Technol Cancer Res Treat
. 2023 Dec;
22:15330338231216011.
PMID: 38105493
Oligometastatic prostate cancer is a term that is most often used to refer to limited sites of disseminated tumor growth following primary radical prostatectomy (RP) or radiotherapy (RT), while de...
3.
Mao Y, Chandramouli S, Xu W, Hoefer M
Phys Rev Lett
. 2023 Oct;
131(14):147201.
PMID: 37862632
The observation of traveling breathers (TBs) with large-amplitude oscillatory tails realizes an almost 50-year-old theoretical prediction [E. A. Kuznetsov and A. V. Mikhailov, Stability of stationary waves in nonlinear weakly...
4.
Hu M, Mao Y, Guan C, Tang Z, Bao Z, Li Y, et al.
Front Oncol
. 2023 Feb;
13:1047388.
PMID: 36845723
Background: Androgen-deprivation therapy (ADT) is used for the treatment of prostate cancer. However, the specific risk factors for the development of castration-resistant disease are still unclear. The present study sought...
5.
Mao Y, Yang G, Li Y, Liang G, Xu W, Hu M
Cancers (Basel)
. 2022 Aug;
14(15).
PMID: 35954408
Despite aggressive treatment and androgen-deprivation therapy, most prostate cancer patients ultimately develop castration-resistant prostate cancer (CRPC), which is associated with high mortality rates. However, the mechanisms governing the development of...
6.
Mao Y, Hu M, Yang G, Gao E, Xu W
World J Surg Oncol
. 2022 Aug;
20(1):255.
PMID: 35945562
Background: Whether cytoreductive prostatectomy (CRP) should be performed in patients with oligometastatic prostate cancer (OPC) remains controversial. The goal of this systematic meta-analysis was to assess the efficacy of CRP...
7.
Zhou Y, Fan Y, Mao Y, Lou M, Liu X, Yuan K, et al.
Biomark Med
. 2022 Feb;
16(7):523-535.
PMID: 35199566
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related deaths. The protein plays a significant role in tumor development. We set up a tissue microarray (containing 140 NSCLC and...
8.
Deng C, Zhang Y, Mao Y, Fan J, Suo J, Zhang Z, et al.
IEEE Trans Pattern Anal Mach Intell
. 2019 Oct;
43(4):1380-1393.
PMID: 31603813
Compressive sensing technique allows capturing fast phenomena at a much higher frame rate than the camera sensor, by recovering a frame sequence from their encoded combination. However, most conventional compressive...